Roche Falls After Full-Year Profit Misses Analyst Estimates

  • Swiss drugmaker blames increased tax rate of almost 27 percent
  • Roche sees 2016 sales having low- to mid-single digit growth

Roche Holding AG declined the most in more than five months after Europe’s largest drugmaker reported full-year profit that missed analyst estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.